세계의 비타민 B군 원료 시장(2024-2028년)

The vitamin B-complex ingredients market is forecasted to grow by USD 790.27 mn during 2023-2028, accelerating at a CAGR of 4.7% during the forecast period. The report on the vitamin B-complex ingredients market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing health and wellness awareness, rising consumer preference for fortified foods, and a vast prevalence of vitamin B preferences.

Technavio's vitamin B-complex ingredients market is segmented as below:

By Distribution Channel

• Offline
• Online

By End-user

• Nutraceuticals and dietary supplements
• Food and beverage industry
• Pharmaceuticals
• Cosmetics and personal care
• Animal feed

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing demand for nutritional supplements as one of the prime reasons driving the vitamin B-complex ingredients market growth during the next few years. Also, rising innovation and product development and rising demand for natural and organic sources will lead to sizable demand in the market.

The report on the vitamin B-complex ingredients market covers the following areas:

• Vitamin B-complex ingredients market sizing
• Vitamin B-complex ingredients market forecast
• Vitamin B-complex ingredients market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vitamin B-complex ingredients market vendors that include BASF SE, Bayer AG, Blackmores Ltd., Country Life Vitamins LLC, GNC Holdings LLC, Haleon Plc, Jarrow Formulas Inc., Koninklijke DSM NV, Life Extension Foundation Buyers Club Inc., Lonza Group Ltd., Nestle SA, NOW Health Group Inc., Nutricost, Otsuka Holdings Co. Ltd., Solgar Inc., Swanson Health Products Inc., Swisse Wellness Pty Ltd., Thorne HealthTech Inc., Vitabiotics Ltd., and WN Pharmaceuticals Ltd. Also, the vitamin B-complex ingredients market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global vitamin B-complex ingredients market 2018 - 2022
• 4.2 Distribution Channel Segment Analysis 2018 - 2022
• 4.3 End-user Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• 6.2 Comparison by Distribution Channel
• 6.3 Offline - Market size and forecast 2023-2028
• 6.4 Online - Market size and forecast 2023-2028
• 6.5 Market opportunity by Distribution Channel

7 Market Segmentation by End-user

• 7.1 Market segments
• 7.2 Comparison by End-user
• 7.3 Nutraceuticals and dietary supplements - Market size and forecast 2023-2028
• 7.4 Food and beverage industry - Market size and forecast 2023-2028
• 7.5 Pharmaceuticals - Market size and forecast 2023-2028
• 7.6 Cosmetics and personal care - Market size and forecast 2023-2028
• 7.7 Animal feed - Market size and forecast 2023-2028
• 7.8 Market opportunity by End-user

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 China - Market size and forecast 2023-2028
• 9.9 Germany - Market size and forecast 2023-2028
• 9.10 UK - Market size and forecast 2023-2028
• 9.11 Canada - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 BASF SE
• 12.4 Bayer AG
• 12.5 Blackmores Ltd.
• 12.6 Country Life Vitamins LLC
• 12.7 GNC Holdings LLC
• 12.8 Jarrow Formulas Inc.
• 12.9 Koninklijke DSM NV
• 12.10 Lonza Group Ltd.
• 12.11 Nestle SA
• 12.12 NOW Health Group Inc.
• 12.13 Otsuka Holdings Co. Ltd.
• 12.14 Solgar Inc.
• 12.15 Thorne HealthTech Inc.
• 12.16 Vitabiotics Ltd.
• 12.17 WN Pharmaceuticals Ltd.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations